These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 21954269
21. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P. J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189 [Abstract] [Full Text] [Related]
22. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991 [Abstract] [Full Text] [Related]
23. Targeting rubella for elimination. Taneja DK, Sharma P. Indian J Public Health; 2012 Feb; 56(4):269-72. PubMed ID: 23354136 [Abstract] [Full Text] [Related]
24. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R. Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454 [Abstract] [Full Text] [Related]
25. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica. Morice A, Avila-Aguero ML, Salas-Peraza D, Soriano A, Castillo-Solórzano C. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S690-7. PubMed ID: 21954268 [Abstract] [Full Text] [Related]
26. Vaccination coverage in Haiti: results from the 2009 national survey. Rainey JJ, Lacapère F, Danovaro-Holliday MC, Mung K, Magloire R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman ET. Vaccine; 2012 Feb 21; 30(9):1746-51. PubMed ID: 22227146 [Abstract] [Full Text] [Related]
27. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students. Abd Elaziz KM, Sabbour SM, Dewedar SA. Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454 [Abstract] [Full Text] [Related]
28. Advocacy and resource mobilization for rubella elimination in Guatemala. Flores A, Villeda JA, Rodríguez-Fernández R, Chévez AE, Barrera L, Tezaguic R, Cajas C, Oliva LV, Molina J, Castillo-Solórzano C. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S598-602. PubMed ID: 21954253 [Abstract] [Full Text] [Related]
29. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 Sep 01; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
30. [Analysis on the changing of age patterns among rubella patients after rubella vaccine immunization for children in Shandong Province, China]. Xu Q, Xu AQ, Song LZ, Zhang L, Xiao ZK, Wang CY, Li MS, Wang AL, Li Z. Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov 01; 26(11):861-3. PubMed ID: 16676605 [Abstract] [Full Text] [Related]
31. The national measles and rubella campaign--one year on. Commun Dis Rep CDR Wkly; 1995 Nov 10; 5(45):237. PubMed ID: 8541943 [No Abstract] [Full Text] [Related]
32. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M. Commun Dis Intell; 2000 Jun 10; Suppl():v-83. PubMed ID: 12049363 [Abstract] [Full Text] [Related]
33. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
34. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016. Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM. PLoS One; 2018 Apr 25; 13(7):e0199786. PubMed ID: 29965975 [Abstract] [Full Text] [Related]
35. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017. Minta AA, Andre-Alboth J, Childs L, Nace D, Rey-Benito G, Boncy J, Adrien P, Francois J, Phaïmyr Jn Charles N, Blot V, Vanden Eng J, Priest JW, Rogier E, Tohme RA. Am J Trop Med Hyg; 2020 Oct 25; 103(4):1717-1725. PubMed ID: 32618256 [Abstract] [Full Text] [Related]
36. Congenital rubella syndrome: progress and future challenges. Morice A, Ulloa-Gutierrez R, Avila-Agüero ML. Expert Rev Vaccines; 2009 Mar 25; 8(3):323-31. PubMed ID: 19249974 [Abstract] [Full Text] [Related]
37. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S664-8. PubMed ID: 21954264 [Abstract] [Full Text] [Related]
38. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM. J Med Virol; 1997 Jan 01; 51(1):32-5. PubMed ID: 8986946 [Abstract] [Full Text] [Related]
39. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N. BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586 [Abstract] [Full Text] [Related]
40. Successful control and impending elimination of measles in the Islamic Republic of Iran. Zahraei SM, Gouya MM, Azad TM, Soltanshahi R, Sabouri A, Naouri B, Alexander JP. J Infect Dis; 2011 Jul 12; 204 Suppl 1():S305-11. PubMed ID: 21666178 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]